Add to ORKGThe Author(s) 2014. This article is published with open access at Springerlink.com Introduction: The effect of exenatide in weight loss has been reported. Presented here is a case of a morbidly obese patient with type 2 diabetes using exenatide who dramatically lost her body weight in a year and experienced improve
Aims: To investigate the effect of exenatide on glucose disposal, insulin secretion, ß-cell function...
Background and objective: Exenatide is an analogue of GLP1 designed to improve the glycemic control ...
OBJECTIVEdTo investigate the effect of treatment with the glucagon-like peptide 1 receptor agonist e...
Background / Aims: Exenatide is a glucagon-like peptide-type 1 (GLP-1) approved for treatment of dia...
Thesis (M.Nurs.), College of Nursing, Washington State UniversityThe prevalence of type 2 diabetes c...
BackgroundMost type 2 diabetes mellitus patients are obese and have obesity related vascular complic...
Background: Most type 2 diabetes mellitus patients are obese and have obesity related vascular compl...
BACKGROUND: Weight loss, especially fat mass reduction, helps to improve blood glucose control, insu...
Type 2 diabetes mellitus (T2DM) is a well-recognized risk factor for the development of cardiovascul...
Peggy Soule Odegard1, Anthony DeSantis21School of Pharmacy, 2Division of Metabolism, Endocrinology a...
Catherine A Schnabel, Matthew Wintle, Orville KoltermanAmylin Pharmaceuticals, Inc, 9360 Towne Centr...
Abstract Background Weight loss, especially fat mass reduction, helps to improve blood glucose contr...
Introduction: Obesity is a major health threat in the Western world because of its high incidence an...
AIM: The study objective was to analyze, in everyday practice, the long-term metabolic effects of ex...
Aims: To investigate the effect of exenatide on glucose disposal, insulin secretion, ß-cell function...
Aims: To investigate the effect of exenatide on glucose disposal, insulin secretion, ß-cell function...
Background and objective: Exenatide is an analogue of GLP1 designed to improve the glycemic control ...
OBJECTIVEdTo investigate the effect of treatment with the glucagon-like peptide 1 receptor agonist e...
Background / Aims: Exenatide is a glucagon-like peptide-type 1 (GLP-1) approved for treatment of dia...
Thesis (M.Nurs.), College of Nursing, Washington State UniversityThe prevalence of type 2 diabetes c...
BackgroundMost type 2 diabetes mellitus patients are obese and have obesity related vascular complic...
Background: Most type 2 diabetes mellitus patients are obese and have obesity related vascular compl...
BACKGROUND: Weight loss, especially fat mass reduction, helps to improve blood glucose control, insu...
Type 2 diabetes mellitus (T2DM) is a well-recognized risk factor for the development of cardiovascul...
Peggy Soule Odegard1, Anthony DeSantis21School of Pharmacy, 2Division of Metabolism, Endocrinology a...
Catherine A Schnabel, Matthew Wintle, Orville KoltermanAmylin Pharmaceuticals, Inc, 9360 Towne Centr...
Abstract Background Weight loss, especially fat mass reduction, helps to improve blood glucose contr...
Introduction: Obesity is a major health threat in the Western world because of its high incidence an...
AIM: The study objective was to analyze, in everyday practice, the long-term metabolic effects of ex...
Aims: To investigate the effect of exenatide on glucose disposal, insulin secretion, ß-cell function...
Aims: To investigate the effect of exenatide on glucose disposal, insulin secretion, ß-cell function...
Background and objective: Exenatide is an analogue of GLP1 designed to improve the glycemic control ...
OBJECTIVEdTo investigate the effect of treatment with the glucagon-like peptide 1 receptor agonist e...